Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Liver Cancer

Clinical Trial at: Texas Oncology - Fort Worth

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

1001 12th Ave, Suite 200
Fort Worth, TX 76104
P: (817) 850-2000

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Parker

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

9397 Crown Crest Blvd, Suite 421
Parker, CO 80138
P: (303) 805-7744

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Plano

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

3705 West 15th Street
Plano, TX 75075
P: (972) 867-3577

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Plano

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, TX 75093
P: (972) 596-7801

More Details View Practice Page

Lymphomas

Clinical Trial at: Compass Oncology - Portland

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

9555 SW Barnes Rd, Suite 150
Portland, OR 97225
P: (503) 297-7403

More Details View Practice Page

Lymphomas

Clinical Trial at: Compass Oncology - Portland

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

265 North Broadway
Portland, OR 97227
P: (503) 280-1223

More Details View Practice Page

Lymphomas

Clinical Trial at: Compass Oncology - Portland

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Pueblo

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

3676 Parker Blvd, Suite 350
Pueblo, CO 81008
P: (719) 296-6000

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Rockville

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

9905 Medical Center Dr, Suite 200
Rockville, MD 20850
P: (301) 424-6231

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - San Antonio

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

4411 Medical Dr, Suite 100
San Antonio, TX 78229
P: (210) 595-5300

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

10460 N 92nd St, Suite 402
Scottsdale, AZ 85258
P: (480) 860-2540

More Details View Practice Page

Lymphomas

Clinical Trial at: The Hope Center for Cancer Care - Warren

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

1745 Niles Cortland Road NE (Route 46), Suite 5
Warren, OH 44484
P: (330) 856-8600

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Silver Spring

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

12210 Plum Orchard Dr, Suite 211
Silver Spring, MD 20904
P: (301) 933-3216

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Silver Spring

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

2730 University W Blvd, Suite 400
Silver Spring, MD 20902
P: (301) 942-9220

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Springfield

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

3377 Riverbend Drive, Suite 500
Springfield, OR 97477
P: (888) 384-9822

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Sugar Land

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

1350 First Colony Blvd
Sugar Land, TX 77479
P: (281) 277-5200

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - The Woodlands

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

9200 Pinecroft, Suite 450
The Woodlands, TX 77380
P: (281) 296-0365

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

8820 Huron St
Thornton, CO 80260
P: (303) 386-7622

More Details View Practice Page

Pages